Pipamperone



Pipamperone
Systematic (IUPAC) name
1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-(1-piperidyl)piperidine-4-carboxamide
Identifiers
CAS number  ?
ATC code N05AD05
PubChem 4830
Chemical data
O2 
Mol. mass 375.480 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Pipamperone is an antipsychotic butyrophenone derivative) used in the treatment of schizophrenia. Pipamperone is known to the general public under the marketed brand name Dipiperon®.

Pipamperone was discovered at Janssen Pharmaceutica in 1960.

References

  • Fouks, Mathis, Gilbert, Ferragu, Houssait, Lerno, Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone, Ann Med Psychol (Paris). 1966 Dec;124(5):677-81.
  • Deberdt R., Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation, Acta Psychiatr Belg. 1976 Jan-Feb;76(1):157-66.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pipamperone". A list of authors is available in Wikipedia.